May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Aiforia Technologies, an expert provider of AI solutions for image analysis, and NeuroScience Associates (NSA Labs®), a leading authority in neurohistology services, announced today a collaboration to uncover the pathophysiology behind...

Please join Dr. David Rimm and Dr. Stine Harder at Visiopharm’s workshop at the USCAP Annual Meeting in Los Angeles. Register here This workshop is divided into two parts. In the first part, we focus on automatic phenotyping in the context...

Originally posted 18 February 2014 Like most boys, my father was my idol, my hero, like the Harry Chapin song goes, I wanted to grow up and be just like him. He worked hard and played harder.  He was a large man with a larger heart.  If...

The Alliance is continuing to pave the way for regulatory science advancements in Digital Pathology. Hosting the Alliance 2020 meeting on February 27 & 28, the Alliance continues to successively bring in larger stakeholders in what is sure...

On June 25th – 26th 2020, 40+ presentations will examine the latest advancements in digital imaging technology and image analysis techniques. Learn how AI and machine learning is being applied to primary diagnosis and clinical research...

Alliance 2020 February 27 & February 28, 2020 JW Marriott Los Angeles L.A. Live – Gold 4 Ballroom (SUPPORTED IN PART BY THE DIGITAL PATHOLOGY FOUNDATION AND CENTER FOR INTEGRATED DIAGNOSTICS AT MASSACHUSETTS GENERAL HOSPITAL) REGISTER...

OR

platinum partners

gold partners

Silver Partners

Media Partners